These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7922383)

  • 21. Current prospects for the treatment of clinical sepsis.
    Suffredini AF
    Crit Care Med; 1994 Jul; 22(7):S12-8. PubMed ID: 8026188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental gram-negative sepsis.
    Morrison DC; Bucklin SE
    Scand J Infect Dis Suppl; 1996; 101():3-8. PubMed ID: 9060044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-protection by anti-core glycolipid antibodies: evidence from animal experiments.
    Hustinx WN; Kraaijeveld K; Hoepelman AI; Verhoef J
    J Antimicrob Chemother; 1997 Oct; 40(4):475-83. PubMed ID: 9372415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular biology of endotoxin antagonism.
    Lazaron V; Dunn DL
    World J Surg; 2002 Jul; 26(7):790-8. PubMed ID: 11948366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy of gram-negative sepsis in man with anti-endotoxin antibodies: a review.
    Wortel CH; Ziegler EJ; van Deventer SJ
    Prog Clin Biol Res; 1991; 367():161-78. PubMed ID: 1924425
    [No Abstract]   [Full Text] [Related]  

  • 26. Antiendotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions.
    Opal SM; Yu RL
    Drugs; 1998 Apr; 55(4):497-508. PubMed ID: 9561340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-endotoxin monoclonal antibodies in the treatment of gram-negative germ sepsis].
    Baumgartner JD
    Rev Prat; 1991 Jun; 41(16):1479-82. PubMed ID: 1853112
    [No Abstract]   [Full Text] [Related]  

  • 28. Accelerated internalization and detoxification of endotoxin by anti-lipopolysaccharide antibody is an Fc receptor--mediated process.
    Lazaron V; Leslie DB; Wasiluk KR; Dunn DL
    Surgery; 2001 Aug; 130(2):192-7. PubMed ID: 11490348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current developments in the field of infection caused by gram-negative microorganisms; passive immunization using anti-endotoxin antibodies].
    van Deventer SJ; ten Cate JW; Appelmelk BJ
    Ned Tijdschr Geneeskd; 1987 Oct; 131(43):1907-10. PubMed ID: 3317073
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis.
    Klaerner HG; Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Johnston JW; Dunn DL
    J Surg Res; 1997 May; 69(2):249-54. PubMed ID: 9224390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Generation and characterization of avian vitelline antibodies against lipopolysaccharide and lipid A. 2. Investigations of specificity of egg yolk antibodies (IgY) against endotoxin].
    Sasse M; Hlinak A
    Berl Munch Tierarztl Wochenschr; 1998 Apr; 111(4):127-33. PubMed ID: 9581346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy in the management of sepsis.
    Sikora JP
    Arch Immunol Ther Exp (Warsz); 2002; 50(5):317-24. PubMed ID: 12455865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial and immunoregulatory functions of lactoferrin and its potential therapeutic application.
    Caccavo D; Pellegrino NM; Altamura M; Rigon A; Amati L; Amoroso A; Jirillo E
    J Endotoxin Res; 2002; 8(6):403-17. PubMed ID: 12542852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Protective properties of antibodies raised against conjugates of endotoxin core oligosaccharides with proteins].
    Jachymek W
    Postepy Hig Med Dosw; 1995; 49(1):171-8. PubMed ID: 8657614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Monoclonal antibodies in the treatment of sepsis caused by Gram-negative microorganisms].
    Otero AJ; Linares M
    Rev Cubana Med Trop; 1998; 50(1):31-5. PubMed ID: 9842265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and application of a novel ligand for affinity chromatography based removal of endotoxin from antibodies.
    McAllister LA; Hixon MS; Schwartz R; Kubitz DS; Janda KD
    Bioconjug Chem; 2007; 18(2):559-66. PubMed ID: 17315943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The screening and isolation of an effective anti-endotoxin monomer from Radix Paeoniae Rubra using affinity biosensor technology.
    Genfa L; Jiang Z; Hong Z; Yimin Z; Liangxi W; Guo W; Ming H; Donglen J; Lizhao W
    Int Immunopharmacol; 2005 Jun; 5(6):1007-17. PubMed ID: 15829416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiendotoxin agents share molecular homology within their lipopolysaccharide binding domains.
    Kellogg TA; Weiss CA; Johnston JW; Wasiluk KR; Dunn DL
    J Surg Res; 1999 Jul; 85(1):136-41. PubMed ID: 10383850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
    Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.